Skip to main content
AAPS Open
Fig. 14 | AAPS Open

Fig. 14

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 14

Dissolution of 600 µM Yomesan-niclosamide at nominal pH 8.85. A Optical microscope images of Yomesan-niclosamide particles before (t = 0mins), during (t = 120 min and 180 min), and after equilibration (day 2). B Dissolution profile from Fig. 8C, extended to day 2. 40× objective,. Scale bars are 10 μm in bright field Kohler illumination optics (Nikon Diaphot)

Back to article page